U.S. market Closed. Opens in 5 hours 3 minutes

PYXS | Pyxis Oncology, Inc. Stock Overview

(Stock Exchange: NASDAQ)
Day's Range 3.80 - 4.31
52 Week Range 1.3500 - 6.85
Beta 1.49
Implied Volatility 297.69%
IV Rank 48.42%
Day's Volume 937,287
Average Volume 535,677
Shares Outstanding 59,422,943
Market Cap 226,995,642
Sector Healthcare
Industry Biotechnology
IPO Date 2021-10-08
Valuation
Profitability
Growth
Health
P/E Ratio -3.60
Forward P/E Ratio -1.24
EPS -1.06
1YR Price Target 9.00
Dividend Yield N/A
Dividend Per Share N/A
Dividend ExDate N/A
Dividend PayDate N/A
Employees 55
Country USA
Website PYXS
Pyxis Oncology Inc is a clinical-stage oncology company focused on developing a multi-modality portfolio of next-generation therapeutics to target difficult-to-treat cancers and improve the quality of life for patients. It develops the product candidates to directly kill tumor cells and address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion. Its lead ADC product candidate is PYX-201, an investigational human IgG1 isotype site-specifically conjugated with an auristatin toxin targeting EDB that initially develop for solid tumors, including NSCLC, hormone receptor-positive breast, ovarian and thyroid cancer. The IO product candidate is PYX-106, designed to block Siglec-15-mediated suppression of T-cell proliferation and function.
PYXS's peers: CYTO, DRUG, PYPD, ZURA, EFTR, ELEV, MREO, PDSB, XFOR, CRVS, TERN, ZVSA, OCEA, ICVX, INZY, HOOK, VTVT, CDIO
*Chart delayed
Analyzing fundamentals for PYXS we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is weak. For more detailed analysis please see PYXS Fundamentals page.

Watching at PYXS technicals we can see that long-term trend is bearish, while middle-term trend is bullish, as well as bullish short-term trend. More technicals details can be found on PYXS Technicals page.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙